Brainsway Ltd 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Brainsway Ltd in the fourth quarter 2025?
Brainsway Ltd achieved a return on average equity (ROE) of 10.53 % in its fourth quarter 2025, this is above BWAY's average return on equity of -10.53%.
Brainsway Ltd shareholder's equity over the 12 months ending in its fourth quarter 2025 are valued at $72 million

ROE has advanced compared to 4.22% in the third quarter 2025, due to net income growth.

Within the Medical Equipment & Supplies industry 41 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2025 from 0 to 1250.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Equity Change	17.41 %	17.41 %	58.52 %	17.41 %	-
Y / Y Net Income Change	159.33 %	-	-	-	-30.4 %
Net Income (TTM) in Millions	8	3	3	3	3
Return On Equity (TTM)	10.53 %	4.22 %	4.39 %	4.85 %	5.08 %
BWAY's Total Ranking	# 1250	# 0	#	#	#
Equity (TTM) in Millions	73	73	68	73	62
Seq. Equity Change	0 %	7.38 %	-6.88 %	17.41 %	0 %
Seq. Net Income Change	-	-	-	-	-

Back to BWAY Management Effectiveness >> BWAY's 5 Years Annual ROE >> Compare BWAY ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 42
Sector	# 158
Overall	# 1250

Return On Equity Statistics
High	Average	Low
10.35 %	-10.53 %	-29.41 %
(Dec 31 2025)		(Dec 31 2022)

BWAY Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	73	62	42	45	57
Y / Y Equity Change	17.41 %	49.86 %	-8.41 %	-20.81 %	191.97 %
Net Income in Millions	8	3	-4	-13	-6
Y / Y Net Income Change	159.33 %	-	-	-	-
Return On Equity	10.35 %	4.69 %	-10.09 %	-29.41 %	-11.27 %

Back to BWAY Management Effectiveness >> BWAY's 5 Years Annual ROE >> Compare BWAY ROE to its Competitors

Annual Roe Comment

In 2025 ROE improved to 10.35 % compared to the previous year, due to net income growth.

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
BWAY's' Return on Equity at Yahoo Finance
BWAY's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for BWAY's Competitors
Subscribers only: Roe for Brainsway Ltd 's Suppliers
Subscribers only: Return On Equity for BWAY's Customers

Companies with similar Return On Equity at Dec 31 2025, within Healthcare Sector	ROE
Waters Corporation	28.52 %
Puma Biotechnology Inc	27.81 %
Resmed Inc	25.18 %
Encompass Health Corporation	24.76 %
Prestige Consumer Healthcare Inc	24.66 %
Catalyst Pharmaceuticals Inc	24.32 %
Collegium Pharmaceutical Inc	24.11 %
Xoma Royalty Corporation	23.97 %
Chemed Corporation	23.92 %
Iradimed Corporation	23.83 %
Lifevantage Corp	23.04 %
Hims and Hers Health Inc	22.99 %
Vertex Pharmaceuticals Inc	22.70 %
Pacs Group Inc	22.54 %
Spero Therapeutics Inc	22.53 %
Iqvia Holdings Inc	22.05 %
Ge Healthcare Technologies Inc	21.90 %
Msa Safety Inc	21.82 %
Mimedx Group Inc	21.24 %
Universal Health Services Inc	21.19 %
Inspire Medical Systems inc	21.07 %
Astrazeneca Plc	21.00 %
Haemonetics Corporation	20.80 %
Sbc Medical Group Holdings Incorporated	20.79 %
Lantheus Holdings Inc	20.58 %
Electromed Inc	20.54 %
Teva Pharmaceutical Industries Limited	20.07 %
Harmony Biosciences Holdings inc	19.84 %
Pediatrix Medical Group Inc	19.58 %
United Therapeutics Corporation	19.30 %

Date modified: 2026-04-24T15:35:29+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.